" Tony Potts, a 69-year-old retiree living in Ormond Beach, i..."

#5906444

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, waits to receive his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906446

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906448

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906450

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906454

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, removes his face mask to allow Clinical Research Coordinator Angela Hammerle to check his temperature before receiving his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906456

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, has his temperature checked by Clinical Research Coordinator Angela Hammerle before receiving his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906458

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, is examined by Dr. Bruce Rankin, Medical Director at Accel Research Sites, before Potts receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906460

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, is examined by Dr. Bruce Rankin, Medical Director at Accel Research Sites, before Potts receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906462

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, consults with Clinical Research Coordinator Angela Hammerle after receiving his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#5906464

5 August 2020

Tony Potts, a 69-year-old retiree living in Ormond Beach, departs after receiving his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites on August 4, 2020 in DeLand, Florida, US. Potts is one of 30,000 participants nationwide to be recruited for the Moderna trial who will receive two injections about a month apart and be monitored for two years.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.